EQR
31
-2
PEP
39
12
XYL
56
-6
FRT
51
-2
MHK
43
-2
SIG
37
-3
PNC
61
-2
WBA
41
-3
AVGO
63
-3
CNP
52
-10
FDX
46
2
SYF
65
-2
RRC
65
-4
COST
45
-3
MSFT
65
-3
ES
39
4
ORLY
57
4
AMAT
54
-4
CVX
28
2
AMGN
28
13
EQR
31
-2
PEP
39
12
XYL
56
-6
FRT
51
-2
MHK
43
-2
SIG
37
-3
PNC
61
-2
WBA
41
-3
AVGO
63
-3
CNP
52
-10
FDX
46
2
SYF
65
-2
RRC
65
-4
COST
45
-3
MSFT
65
-3
ES
39
4
ORLY
57
4
AMAT
54
-4
CVX
28
2
AMGN
28
13
Financhill
Back

Intellia Therapeutics Vs. Navidea Biopharmaceuticals Industry Stock Comparison

Sell
41

NTLA
Intellia Therapeutics

Last Price:
$9.32
Seasonality Move:
21.05%
Sell
19

NAVB
Navidea Biopharmaceuticals

Last Price:
$0.0007
Seasonality Move:
-4.34%
Sell
41
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $9.16. The Score for NTLA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Navidea Biopharmaceuticals (NAVB) is a Sell

Is Navidea Biopharmaceuticals a Buy, Sell or Hold?

  • The current Navidea Biopharmaceuticals [NAVB] share price is $0.0007. The Score for NAVB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NAVB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $9.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NAVB Stock Price Chart

What is Navidea Biopharmaceuticals's stock price today?

  • The Navidea Biopharmaceuticals share price today is $0.0007
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NAVB is experiencing slight buying pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.31 Buy
Relative Strength Index (14 RSI): 56.38 Buy
Chaikin Money Flow: 1165679 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.86 - 9.02) Buy
Bollinger Bands (100): (7.79 - 10.89) Sell

NAVB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Sell
Relative Strength Index (14 RSI): 45.08 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0017 - 0.0017) Sell
Bollinger Bands (100): (0.0007 - 0.0007) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.88 Buy
20-day SMA: 8.51 Buy
50-day SMA: 8.13 Buy
200-day SMA: 13.82 Sell
8-day EMA: 8.99 Buy
20-day EMA: 8.59 Buy
50-day EMA: 8.64 Buy
200-day EMA: 13.48 Sell

NAVB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0 Sell
20-day SMA: 0 Sell
50-day SMA: 0 Sell
200-day SMA: 0 Sell
8-day EMA: 0 Sell
20-day EMA: 0 Sell
50-day EMA: 0 Sell
200-day EMA: 0.01 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.08 per share, and an increase next year of $0.23 per share.

Navidea Biopharmaceuticals Earnings Growth & NAVB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Navidea Biopharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):